“…In women of African origin, fibroids occur early in their reproductive life, they are more often numerous and larger in size, recurrence occurs more often, and they do not regress after menopause (47). Other risk factors identified in this population (7,(48)(49)(50)(51)(52) include age, early menarche, overweight, and polycystic ovary syndrome. Tumoral molecular biology studies suggest that E 2 metabolism may be altered in women of African origin, because polymorphism in the catecholamine-O-methyl transferase (COMT) gene leading to reduced enzyme activity has been correlated with increased tumor size (53).…”